[Effect of conversion therapy and prognostic factors in patients with advanced intrahepatic cholangiocarcinoma: a real-world study].

PubMed 2026

View at publisher
Authors: J W Liu, K Liang, Y X Lin, Feng Shen, K Wang
DOI: 10.3760/cma.j.cn112139-20251030-00503
Cited by: 0

Abstract

Chemotherapy combined with immunotherapy, as a first-line treatment regimen for patients with advanced ICC, has good antitumor effects and can improve patient prognosis without causing serious new adverse reactions. For patients who can undergo surgical resection after conversion and downstaging, radical surgical resection can improve prognosis compared to continuing systemic therapy.

Fields of Study & Subjects

Cholangiocarcinoma and Gallbladder Cancer Studies Pediatric Hepatobiliary Diseases and Treatments Hepatocellular Carcinoma Treatment and Prognosis

Publication details

Journal / source
PubMed
Volume
64
Issue
4
Pages
337–348
Publication date
1 April 2026
Language
ZH